Literature DB >> 33496862

Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.

Giulia Seghezzo1, Yvonne Van Hoecke2, Laura James1, Donna Davoren2, Elizabeth Williamson2, Neil Pearce2, Damien McElvenny2,3,4, Valentina Gallo5,6,7.   

Abstract

BACKGROUND: The Preclinical Alzheimer Cognitive Composite (PACC) is a composite score which can detect the first signs of cognitive impairment, which can be of importance for research and clinical practice. It is designed to be administered in person; however, in-person assessments are costly, and are difficult during the current COVID-19 pandemic.
OBJECTIVE: To assess the feasibility of performing the PACC assessment with videoconferencing, and to compare the validity of this remote PACC with the in-person PACC obtained previously.
METHODS: Participants from the HEalth and Ageing Data IN the Game of football (HEADING) Study who had already undergone an in-person assessment were re-contacted and re-assessed remotely. The correlation between the two PACC scores was estimated. The difference between the two PACC scores was calculated and used in multiple linear regression to assess which variables were associated with a difference in PACC scores.
FINDINGS: Of the 43 participants who were invited to this external study, 28 were re-assessed. The median duration in days between the in-person and the remote assessments was 236.5 days (7.9 months) (IQR 62.5). There was a strong positive correlation between the two assessments for the PACC score, with a Pearson correlation coefficient of 0·82 (95% CI 0·66, 0·98). The multiple linear regression found that the only predictor of the PACC difference was the time between assessments.
INTERPRETATION: This study provides evidence on the feasibility of performing cognitive tests online, with the PACC tests being successfully administered through videoconferencing. This is relevant, especially during times when face-to-face assessments cannot be performed.

Entities:  

Keywords:  Cognitive decline; Cognitive testing; Mild cognitive impairment; Telemedicine

Year:  2021        PMID: 33496862      PMCID: PMC7836343          DOI: 10.1007/s00415-021-10403-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  Methodological issues in the study of cognitive decline.

Authors:  M C Morris; D A Evans; L E Hebert; J L Bienias
Journal:  Am J Epidemiol       Date:  1999-05-01       Impact factor: 4.897

2.  Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates.

Authors:  Robert J Spencer; Carrington R Wendell; Paul P Giggey; Leslie I Katzel; David M Lefkowitz; Eliot L Siegel; Shari R Waldstein
Journal:  Exp Aging Res       Date:  2013       Impact factor: 1.645

Review 3.  The robust reliability of neuropsychological measures: meta-analyses of test-retest correlations.

Authors:  Matthew Calamia; Kristian Markon; Daniel Tranel
Journal:  Clin Neuropsychol       Date:  2013-06-25       Impact factor: 3.535

4.  Dementia research 2018: current and future population relevance.

Authors:  Carol Brayne
Journal:  Lancet Neurol       Date:  2019-01       Impact factor: 44.182

5.  Reliable Change on Neuropsychological Tests in the Uniform Data Set.

Authors:  Brandon E Gavett; Lee Ashendorf; Ashita S Gurnani
Journal:  J Int Neuropsychol Soc       Date:  2015-08-03       Impact factor: 2.892

6.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Authors:  Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

  6 in total
  2 in total

1.  Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy.

Authors:  Suzan van Amerongen; Dewi K Caton; Rik Ossenkoppele; Frederik Barkhof; Petra J W Pouwels; Charlotte E Teunissen; Annemieke J M Rozemuller; Jeroen J M Hoozemans; Yolande A L Pijnenburg; Philip Scheltens; Everard G B Vijverberg
Journal:  Alzheimers Res Ther       Date:  2022-09-01       Impact factor: 8.823

2.  eHealth tools to assess neurological function: a systematic review protocol for a mapping exercise.

Authors:  Vasco Ribeiro Ferreira; Hamed Seddighi; Lise Beumeler; Esther Metting; Valentina Gallo
Journal:  BMJ Open       Date:  2022-09-26       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.